Meta-analysis of the impact of viral hepatitis on the risk of Parkinson’s disease
返回论文页
|更新时间:2021-08-23
|
Meta-analysis of the impact of viral hepatitis on the risk of Parkinson’s disease
Health Medicine Research and PracticeVol. 17, Issue 1, Pages: 9-14(2020)
作者机构:
重庆医科大学附属第二医院神经内科
作者简介:
基金信息:
DOI:
CLC:R512.6;R742.5
Published:2020,
扫 描 看 全 文
Wang Hui, Liu Xi, Chen Lifen. Meta-analysis of the impact of viral hepatitis on the risk of Parkinson’s disease. [J]. Health Medicine Research and Practice 17(1):9-14(2020)
DOI:
Wang Hui, Liu Xi, Chen Lifen. Meta-analysis of the impact of viral hepatitis on the risk of Parkinson’s disease. [J]. Health Medicine Research and Practice 17(1):9-14(2020)DOI:
Meta-analysis of the impact of viral hepatitis on the risk of Parkinson’s disease
Objective To investigate the impact of viral hepatitis infections(including hepatitis A
B
C
D
and E infection)on the risk of Parkinson′s disease(PD).Methods Literatures on the relationship between viral hepatitis and the risk of PD from January 1965 to October 2019 were obtained by searching in Chinese and English databases.After screening the literatures
quality evaluation was performed and data such as odds ratio(OR)and95%confidence interval(95% CI)were extracted.Meta-analysis was performed using STATA 12.0.Sensitivity analysis and meta-regression analysis were used to find the source of heterogeneity.Publication bias was assessed using the trim-and-fill method.Results A total of 7 articles were included for study.The analyses suggested that hepatitis C virus(HCV)infection is a risk factor for PD(OR=1.19
95%CI=1.01~1.41
P=0.035)
anti-HCV treatment can reduce the risk of PD(OR=0.67
95%CI=0.57~0.79
P<0.001)
and that hepatitis B virus(HBV)infection is not associated with the risk of PD(OR=0.96
95% CI=0.72~1.28
P=0.781).Conclusion HCV infection may increase the risk of PD
which can be reduced via anti-HCV treatment.Therefore
it is necessary to pay attention to the clinical screening and treatment of patients with HCV infection
so as to reduce the incidence of PD and relieve the economic burden for both the patients and the whole society.